Emulate, Inc., founded in Boston, Massachusetts, is a pioneering biotechnology company focused on advancing human health through its innovative Organs-on-Chips technology. This technology replicates organ-level functions using human cells to model healthy and diseased states of organs, providing a more accurate platform for pharmaceutical research, product development, and testing the effects of medicines, chemicals, and foods on human health. Emulate's mission is to revolutionize precision medicine and enhance the predictive power of preclinical testing.
Key figures at Emulate include CEO Jim Corbett, scientific founder Donald Ingber, and co-founder Daniel Levner. The company has achieved significant milestones, including collaborations with Cedars-Sinai Medical Center for precision medicine initiatives. Emulate's Organs-on-Chips technology has garnered attention for its potential to bridge the gap between traditional 2D models and human biology, making a substantial impact on the biotechnology industry by improving the accuracy and efficiency of drug development and safety testing.
